Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Berger recently discussed the ethical problems of selling
Icelandic pedigrees so that genes predisposing to common disorders
could be patented.1 The technical problem "will it work" is also of interest. The belief that multifactorial disorders can be analysed by unifactorial methods underlies the ancestral approach of deCODE.
The company claims, with justification, that it has "formidable capabilities in statistical genetics and uses state of the art techniques of statistical analysis. Since deCODE has access to a large collection of families with extensive pedigrees and family history, the company is able to employ a variety of statistical methods to simplify the search for disease genes. This is particularly important given the competitive nature of large scale genetic analysis."
However, little is said of what these techniques are, or the basis for
the statement that "300 000 genotypes a month is enough to allow the
company to map 12 complex diseases per
Read all Rapid Responses